Under FDA Circular 2021-008 or the Updated Guidelines for the Registration of Drug Products Under Emergency Use (DEU) for COVID-19, licensed drug establishments intending to manufacture and import/ distribute drug products listed in the Philippine COVID-19 Living Recommendations may register as DEU provided that such drug products have a positive recommendation and a registered counterpart with the FDA at the time of the application.
As of 07 January 2022, the following products may be registered as Drug Products under Emergency Use (DEU) for COVID-19:
| Generic Name | Strength | Dosage Form |
| Tocilizumab | 400 mg/20 mL | Concentrate Solution for Infusion (IV) |
| 80 mg/4 mL (20 mg/mL) | Concentrate Solution for Infusion (IV) | |
| 200 mg/10 mL | Concentrate Solution for Infusion (IV) | |
| 160 mg/0.9 mL | Solution for Injection (SC) | |
| Baricitinib | 2 mg | Tablet |
| 4 mg | Tablet | |
| Dexamethasone (as sodium phosphate) | 4 mg/mL | Solution for Injection (IM/IV) |
| 50 mg/mL | Solution for Injection (IM/IV) | |
| 4 mg/mL (8 mg/2 mL) | Solution for Injection (IM/IV) | |
| 5 mg/mL | Solution for Injection (IM/IV) | |
| 5 mg/mL (10 mg/2 mL) | Solution for Injection (IM/IV) | |
| 2 mg/mL | Solution for Injection (IM/IV) | |
| 2 mg/mL (4 mg/2 mL) | Solution for Injection (IM/IV) | |
|
Heparin Sodium |
1000 IU/mL (10,000 IU/10 mL) | Solution for Injection (IV/SC) |
| 5,000 IU/mL (25,000 IU/ 5mL) | Solution for Injection (IV/SC) | |
| 1,000 IU/mL (5,000 IU/ 5mL) | Solution for Injection (IV/SC) | |
| 5000 IU/ mL | Solution for Injection (IV/SC) | |
| 1000 IU/mL | Solution for Injection (IV/SC) | |
|
Enoxaparin Sodium |
20mg/ 0.2mL | Solution for Injection (IV/SC) |
| 40 mg/0.4 mL | Solution for Injection (SC) | |
| 60mg/0.6mL | Solution For Injection (SC) | |
| 4,000 IU Anti-Factor Xa (equivalent to 40mg) / 0.4mL | Solution for Injection (IV/SC) | |
| 2,000 IU Anti-Factor Xa (equivalent to 20mg) / 0.2mL | Solution for Injection (IV/SC) | |
| 6,000 IU Anti-Factor Xa (equivalent to 60mg) / 0.6mL | Solution for Injection (IV/SC) | |
| 8,000 IU Anti-Factor Xa (equivalent to 80mg) / 0.8mL | Solution for Injection (SC) | |
| Bivalirudin | 250 mg | Lyophilized Powder for Injection (IV) |
| Tinzaparin sodium | 10000 anti-Xa IU/mL | Solution For Injection (SC) |
| 20000 anti-Xa IU/mL | Solution For Injection (SC) | |
| Dalteparin Sodium | 2500 I.U/0.2 mL Solution | Solution For Injection In
Pre-Filled Syringe |
| Remdesivir | 100 mg | Lyophilized Powder for Solution for Infusion (IV) |
For the information and guidance of all.